Status: current, Defined. Date: 31-Mar 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3267561000168119 | paclitaxel (as nanoparticle albumin-bound) 250 mg injection, 1 x 250 mg vial (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3267571000168113 | paclitaxel (as nanoparticle albumin-bound) 250 mg injection, 1 vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| paclitaxel (as nanoparticle albumin-bound) 250 mg injection, 1 vial | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| paclitaxel (as nanoparticle albumin-bound) 250 mg injection, 1 vial | has MPUU | paclitaxel (as nanoparticle albumin-bound) 250 mg injection, vial | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Abraxane 250 mg powder for injection, 1 vial | Is a | True | paclitaxel (as nanoparticle albumin-bound) 250 mg injection, 1 vial | Inferred relationship | Some |
Reference Sets
List of Medicines for Brand Consideration reference set
Medicinal product pack reference set
FHIR